Skip to content

Clinical trials

Hepatitis B, Chronic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Country / region: New Zealand Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20054
20061
20072
20081
20094
20122
20131
20146
20154
20165
20174
20188
20208
20218
20225
20235
20246
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Terminated14
Recruiting5
Not yet recruiting2
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche16
Gilead Sciences14
Assembly Biosciences12
Aligos Therapeutics5
Vir Biotechnology, Inc.4
AusperBio Therapeutics Inc.3
Janssen Research & Development, LLC3
Alios Biopharma Inc.2
Arbutus Biopharma Corporation2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic82
Hepatitis B31
Hepatitis9
Hepatitis, Chronic4
Liver Diseases3
DNA Virus Infections2
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
Digestive System Diseases1

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.